NCNMGF
VIR icon

Nano-Cap New Millennium Growth Fund’s Vir Biotechnology VIR Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.4K Hold
7,500
– – 0.06% 127
2026
Q1 		$67.2K Sell
7,500
-2,500
-25% -$19.9K 0.06% 140
2025
Q4 		$60.3K Buy
+10,000
New +$59.5K 0.05% 160

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's VIR Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund held its Vir Biotechnology (VIR) position steady in Q2 2026 at 7,500 shares worth $76.4K. The position accounts for 0.06% of the portfolio, ranked #127.

Nano-Cap New Millennium Growth Fund first reported a position in VIR in Q4 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 7,500 shares of Vir Biotechnology worth $76.4K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up 0.06% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #127 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Vir Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.